Search Within

Eric J Sherman

Formats
  1. Meeting Abstract (187)
  2. Journal Article (144)
  3. Review (6)
  4. Correspondence (5)
  5. Editorial (3)
  6. Research Letter (2)
  7. Book Section (1)
  8. Guidelines (1)
Groups
  1. Department of Medicine (349)
  2. Head and Neck Service (349)
  3. Solid Tumor Oncology Division (349)
  4. Radiation Oncology, Department of (204)
  5. Surgery (172)
  6. Head and Neck Surgery (170)

More Groups

People
  1. Nancy Lee (200)
  2. Nadeem Riaz (149)
  3. David Pfister (127)
  4. Sean McBride (112)
  5. Richard Wong (110)
  6. Alan Ho (90)

More People

Years
  1. 2025 (10)
  2. 2024 (36)
  3. 2023 (24)
  4. 2022 (29)
  5. 2021 (21)
  6. 2020 (38)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (94)
  2. Journal of Clinical Oncology (85)
  3. Annals of Oncology (19)
  4. Cancer (16)
  5. Head & Neck (16)
  6. Oral Oncology (9)

More Publications

Publishers
  1. Elsevier Inc. (111)
  2. American Society of Clinical Oncology (87)
  3. Oxford University Press (28)
  4. Wiley Blackwell (26)
  5. John Wiley & Sons, Inc. (16)
  6. American Medical Association (11)

More Publishers

Results (349)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Registrational results of LOXO-292 in patients with RET-altered thyroid cancers
    Meeting Abstract

    Wirth, L.; Sherman, E.; Drilon, A.; Solomon, B.; Robinson, B.; Lorch, J.; McCoach, C.; Patel, J.; Leboulleux, S.; Worden, F.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Predictors of early immunotherapy response in head and neck cancer: Per lesion analysis of a prospective randomized trial with nivolumab
    Meeting Abstract

    Yu, Y.; Chen, L.; Riaz, N.; Kang, J.; Tsai, C. J.; Sherman, E. J.; Lee, N. Y.; McBride, S. M.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A retrospective analysis of cisplatin dosing strategies when used with radiation on outcomes in head and neck squamous cell carcinoma of the oropharynx
    Meeting Abstract

    Tchekmedyian, V.; Ho, A. L.; Dunn, L.; Fetten, J. V.; Pfister, D. G.; Lobaugh, S.; Zhang, Z.; Kang, J.; Chen, L.; Riaz, N.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase II trial cohort of nivolumab plus ipilimumab in patients (Pts) with recurrent/metastatic adenoid cystic carcinoma (R/M ACC)
    Meeting Abstract

    Tchekmedyian, V.; Sherman, E. J.; Dunn, L.; Fetten, J. V.; Michel, L. S.; Kriplani, A.; Morris, L.; Ostrovnaya, I.; Katabi, N.; Haque, S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Pilot study combining PD-L1 antibody durvalumab (D) with CTLA-4 antibody tremelimumab (T) and stereotactic body radiotherapy (SBRT) to treat metastatic anaplastic thyroid cancer (ATC)
    Meeting Abstract

    Sherman, E. J.; Tsai, C. J.; Zhi, W. I.; Fetten, J. V.; Wu, V.; Ho, A. L.; Riaz, N.; Pfister, D. G.; Lee, N. Y.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Biomarker predictors of outcome from a randomized trial of nivolumab +/- stereotactic body radiotherapy (SBRT) in metastatic (M1) head and neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    McBride, S. M.; Lee, N. Y.; Pfister, D. G.; Sherman, E. J.; Tsai, C. J.; Aghalar, J.; Eng, J.; Zhi, W. I.; McFarland, D. C.; Michel, L. S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Alliance A091404: A phase II study of enzalutamide (NSC# 766085) for patients with androgen receptor-positive salivary cancers
    Meeting Abstract

    Ho, A. L.; Foster, N. R.; Zoroufy, A. J.; Worden, F. P.; Andress, K.; Price, R.; Adkins, D.; Bowles, D. W.; Kang, H.; Burtness, B.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Predictors of early response to immunotherapy in head and neck cancer: A secondary clinical and radiomic analysis of a prospective randomized trial with nivolumab
    Meeting Abstract

    Yu, Y.; Chen, L.; Riaz, N.; Kang, J. J.; Thor, M.; Veeraraghavan, H.; Apte, A.; Tsai, C. J.; Deasy, J. O.; Sherman, E.; more...
    International Journal of Radiation Oncology, Biology, Physics (2019)

    Fulltext@MSK | Save
  • A pilot study of stereotactic body radiotherapy (SBRT) combined with a PD-L1 antibody durvalumab (D) and a CTLA-4 antibody tremelimumab (T) to treat metastatic anaplastic thyroid cancer (ATC)
    Meeting Abstract

    Lee, N.; Tsai, C. J.; Riaz, N.; Wu, V.; Brinkman, T.; Zhi, W.; Fetten, J.; Ho, A.; Pfister, D. G.; Sherman, E.
    International Journal of Radiation Oncology, Biology, Physics (2019)

    Fulltext@MSK | Save
  • TERT promoter mutations among oral cavity cancers: A pattern of failure analysis
    Meeting Abstract

    Yu, Y.; Fan, D.; Song, X.; Chen, L.; Kang, J. J.; Tsai, C. J.; McBride, S.; Sherman, E.; Fetten, J.; Dunn, L.; more...
    International Journal of Radiation Oncology, Biology, Physics (2019)

    Fulltext@MSK | Save